CORONA Remedies Limited
Ashoka WhiteOak bought 1,48,686 shares of Corona Remedies Limited for ₹25.72 crore at ₹1730.00 apiece in a block deal.
Corona Remedies Limited, founded in 2004 and headquartered in Ahmedabad, is a pharmaceutical company manufacturing and distributing medicines across women's healthcare, cardiology, pain management, and urology. The company operates two manufacturing facilities in Gujarat and Himachal Pradesh, holds EU-GMP and WHO certifications, and maintains market leadership positions in multiple therapeutic segments including rank #5 in women's healthcare and pain management.
India equity vehicle of WhiteOak Capital, the Singapore-headquartered manager founded in 2017 by Prashant Khemka, former CIO of Goldman Sachs Asset Management's India Equity and Global Emerging Markets businesses. WhiteOak group manages USD 10.8 bn (~Rs 96,000 cr) across SMAs and funds. Ashoka India Opportunities Fund ranks as the best-performing India UCITS fund since 2018 inception.